DUBLIN, Ohio, May 30, 2019 /PRNewswire/ -- Oncologists
said they see a growing role for artificial intelligence (AI) in
improving the quality of care and patient outcomes according to new
research from Cardinal Health Specialty Solutions.
These findings were released today in the fifth edition
of Oncology Insights, a research-based report series
analyzing the views of more than 180 U.S. oncologists.
When asked about the future impact of AI on the oncology
industry, 53 percent of participating oncologists said they are
"excited." More than half of oncologists said they anticipate AI
will help enhance the quality of care (53 percent), improve
clinical outcomes, and (57 percent) drive operational efficiencies
(58 percent) in three or more years. Nearly half (47 percent)
also expect it to lower the cost of care.
Other key findings demonstrating oncologists' optimism about
AI:
- When asked to identify the most valuable benefit that AI could
provide to their practice, 37 percent said automating
administrative tasks to allow oncologists to focus more on patients
and 27 percent said identifying best treatment paths to help them
choose the right drug the first time.
- Oncologists also cited the potential to predict patients most
at risk of complications and the ability to enhance the accuracy of
diagnostics as key opportunities for AI to improve oncology
care.
"Nearly every day we read of new tools and technologies being
hailed for their potential to improve cancer detection and
treatment, but it is too early to know the full impact these
innovations will have," said Joe DePinto, President of
Cardinal Health Specialty Solutions. "The findings from our new
Oncology Insights research suggest that oncologists are
optimistic about the potential benefits of AI and are eager to
explore the role that data-driven tools may play in improving care
and lowering costs."
About the Survey
The findings in Oncology
Insights are based on web-based surveys conducted in
advance of three Cardinal Health Summits conducted in February,
March and April 2019. The survey
included participation from more than 180 U.S oncologists,
representing a diverse mix of community and hospital-based
practices. The report also includes viewpoints from Chief Medical
Officer Bruce Feinberg, DO, and Eli
Phillips, Jr., Vice President of Insights and
Engagement.
About Cardinal Health
Cardinal Health, Inc. is a
global, integrated healthcare services and products company,
providing customized solutions for hospitals, healthcare systems,
pharmacies, ambulatory surgery centers, clinical laboratories and
physician offices worldwide. The company enhances supply chain
efficiency for clinically proven medical products, pharmaceuticals
and cost-effective solutions. To combat prescription drug misuse,
the Cardinal Health Foundation and its education partners created
Generation Rx, a national drug prevention education and awareness
program. The Foundation actively supports an array of other
solutions, including efforts to reduce opioid prescribing, promote
drug take back and safe disposal and expand collaborative community
work.
Cardinal Health is backed by nearly 100 years of experience with
operations in nearly 46 countries. For more information, visit
cardinalhealth.com. Follow us on Twitter, Facebook and
LinkedIn.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/cardinal-health-oncology-insights-fifth-edition-oncologists-are-optimistic-artificial-intelligence-will-enhance-the-quality-of-patient-care-and-outcomes-300857409.html
SOURCE Cardinal Health